◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Satellos Bioscience Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Cost Of Revenue -- -- -- 94,053
Gross Profit -- -- -- -94,053
Selling General And Administration 5.2M 4.6M 2.9M 1.1M
General And Administrative Expense 5.2M 4.6M 2.9M 1.1M
Research And Development 13.7M 6.6M 2.8M 1.6M
Depreciation And Amortization In Income Statement 13,935 5,277 248,305 129,947
Other Operating Expenses 540,695 437,208 292,514 852,716
Operating Expense 19.4M 11.7M 6.2M 3.7M
Operating Income -19.4M -11.7M -6.2M -3.7M
EBIT -19.6M -11.8M -8.3M -11.4M
Interest Expense 0.00 133,424 0.00 772,797
Interest Expense Non Operating 0.00 133,424 0.00 772,797
Interest Income 955,274 1.0M 46,419 6,263
Interest Income Non Operating 955,274 1.0M 46,419 6,263
Net Interest Income 955,274 871,401 46,419 -766,534
Other Income Expense -1.2M -1.2M -2.2M -7.7M
Other Non Operating Income Expenses -- -- -35,862 -34,385
Special Income Charges -2.8M -321,122 -2.1M -7.7M
Restructuring And Mergern Acquisition -- -- 0.00 7.7M
Gain On Sale Of Security 1.6M -871,401 -49,366 4,619
Pretax Income -19.6M -12.0M -8.3M -12.2M
Tax Provision 0.00 0.00 3,684 0.00
Tax Effect Of Unusual Items 0.00 0.00 -570,085 0.00
Net Income From Continuing And Discontinued Operation -19.6M -12.0M -8.3M -12.2M
Net Income From Continuing Operation Net Minority Interest -19.6M -12.0M -8.3M -12.2M
Net Income Including Noncontrolling Interests -19.6M -12.0M -8.3M -12.2M
Net Income Common Stockholders -19.6M -12.0M -8.3M -12.2M
Net Income -19.6M -12.0M -8.3M -12.2M
EBITDA -19.6M -11.8M -8.1M -11.3M
Normalized EBITDA -18.4M -10.6M -5.9M -3.6M
Reconciled Depreciation 13,935 5,277 248,305 129,947
Basic EPS 2.09 -1.63 -2.83 -6.02
Diluted EPS 2.09 -1.63 -2.83 -6.02
Basic Average Shares 9.6M 7.2M 3.0M 2.0M
Diluted Average Shares 9.6M 7.2M 3.0M 2.0M
Total Unusual Items -1.2M -1.2M -2.2M -7.7M
Total Unusual Items Excluding Goodwill -1.2M -1.2M -2.2M -7.7M
Tax Rate For Calcs 0.00 0.00 0.26 0.00
Normalized Income -18.4M -10.8M -6.7M -4.5M
Amortization -- 0.00 245,358 129,367
Amortization Of Intangibles Income Statement -- 0.00 245,358 129,367
Depreciation Amortization Depletion Income Statement 13,935 5,277 248,305 129,947
Depreciation Income Statement 13,935 5,277 2,947 580.38
Diluted NI Availto Com Stockholders -19.6M -12.0M -8.3M -12.2M
Impairment Of Capital Assets 2.8M 0.00 2.1M 0.00
Insurance And Claims -- -- 25,268 18,183
Net Income Continuous Operations -19.6M -12.0M -8.3M -12.2M
Net Non Operating Interest Income Expense 955,274 871,401 46,419 -766,534
Other Gand A 1.6M 1.8M 1.2M 353,020
Other Special Charges -- 321,122 -- --
Reconciled Cost Of Revenue -- -- -- 94,053
Salaries And Wages 3.5M 2.7M 1.7M 761,974
Total Expenses 19.4M 11.7M 6.2M 3.7M
Total Operating Income As Reported -19.4M -11.7M -6.2M --
Total Other Finance Cost -- -- -- 934,197
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 40.2M 16.6M 1.4M 3.8M
Cash Cash Equivalents And Short Term Investments 48.7M 29.8M 1.4M 3.8M
Cash Equivalents 15.7M 16.2M 818,597 2.4M
Cash Financial 24.4M 459,068 599,027 1.5M
Other Short Term Investments 8.5M 13.2M -- --
Accounts Receivable -- -- 0.00 1,398
Receivables 436,179 439,469 191,571 414,099
Prepaid Assets 1.8M 111,563 33,893 34,218
Current Assets 50.9M 30.4M 1.6M 4.3M
Gross PPE 3,484 14,322 10,315 7,912
Accumulated Depreciation -- -13,000 -3,684 -1,487
Net PPE 3,484 14,322 6,631 6,425
Goodwill And Other Intangible Assets 0.00 3.0M 2.9M 5.6M
Other Intangible Assets -- -- 3.9M 5.6M
Investments And Advances 0.00 30,906 30,946 0.00
Total Non Current Assets 3,484 3.0M 2.9M 5.6M
Total Assets 50.9M 33.4M 4.6M 9.9M
Accounts Payable 2.1M 783,959 1.1M 885,337
Payables 2.1M 783,959 1.1M 885,337
Payables And Accrued Expenses 3.6M 2.7M 2.1M 1.7M
Current Accrued Expenses 1.5M 1.9M 1.0M 764,842
Current Liabilities 3.6M 2.7M 2.1M 1.7M
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 3.6M 2.7M 2.1M 1.7M
Common Stock 73.7M 46.7M 22.3M 22.2M
Capital Stock 73.7M 46.7M 22.3M 22.2M
Additional Paid In Capital 7.2M 6.4M 2.7M 969,028
Retained Earnings -52.7M -35.8M -23.3M -15.9M
Gains Losses Not Affecting Retained Earnings -151,199 -11,307 -5,158 -1,133
Other Equity Adjustments -151,199 -11,307 -5,158 -1,133
Common Stock Equity 47.3M 30.7M 2.5M 8.2M
Stockholders Equity 47.3M 30.7M 2.5M 8.2M
Total Equity Gross Minority Interest 47.3M 30.7M 2.5M 8.2M
Total Capitalization 47.3M 30.7M 2.5M 8.2M
Net Tangible Assets 47.3M 27.7M -403,036 2.6M
Tangible Book Value 47.3M 27.7M -403,036 2.6M
Working Capital 47.3M 27.7M -439,876 2.6M
Invested Capital 47.3M 30.7M 2.5M 8.2M
Share Issued 13.8M 9.4M 3.5M 2.7M
Ordinary Shares Number 13.8M 9.4M 3.5M 2.7M
Hedging Assets Current 0.00 3,015 2,210 0.00
Machinery Furniture Equipment -- 32,000 10,315 7,912
Other Equity Interest 19.2M 13.4M 804,598 959,468
Other Properties 3,484 14,322 -- 8,192
Taxes Receivable 436,179 439,469 191,571 412,700
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -17.4M -8.7M -4.3M -3.9M
Cash Flow From Continuing Operating Activities -17.4M -8.7M -4.2M -3.9M
Depreciation And Amortization 13,935 5,277 248,305 129,947
Depreciation Amortization Depletion 13,935 5,277 248,305 129,947
Stock Based Compensation 1.5M 1.6M 1.1M 761,974
Change In Working Capital -714,191 278,155 730,180 -380,887
Changes In Account Receivables -- -- 1,314 31,471
Change In Receivables -29,961 -243,480 196,729 -52,861
Change In Payables And Accrued Expense 960,152 598,523 534,925 -306,246
Other Non Cash Items -340,025 133,424 -103,154 7.7M
Capital Expenditure -4,181 -13,569 -2,210 -5,683
Purchase Of PPE -4,181 -13,569 -2,210 -5,683
Net PPE Purchase And Sale -4,181 -13,569 -2,210 -5,683
Sale Of Business -- -- 0.00 1.4M
Purchase Of Investment -26.0M -13.2M 0.00 --
Sale Of Investment 30.4M 0.00 -- --
Net Investment Purchase And Sale 4.4M -13.2M 0.00 --
Investing Cash Flow 4.4M -13.2M -2,210 1.4M
Cash Flow From Continuing Investing Activities 4.4M -13.2M -2,210 1.4M
Issuance Of Debt 0.00 1.7M 0.00 146,329
Repayment Of Debt 0.00 -2.0M 0.00 --
Net Issuance Payments Of Debt 0.00 -284,939 0.00 146,329
Issuance Of Capital Stock 29.8M 24.5M 2.0M 5.6M
Net Common Stock Issuance 29.8M 24.5M 2.0M 5.6M
Financing Cash Flow 37.3M 38.0M 2.0M 5.8M
Cash Flow From Continuing Financing Activities 37.3M 38.1M 2.0M 5.8M
Effect Of Exchange Rate Changes 518,398 -876,677 -55,998 -1,133
Changes In Cash 24.3M 16.1M -2.1M 3.3M
Beginning Cash Position 15.4M 1.5M 3.6M 562,760
End Cash Position 40.2M 16.6M 1.4M 3.8M
Free Cash Flow -17.4M -8.7M -4.3M -4.0M
Amortization Cash Flow -- 0.00 245,358 129,367
Amortization Of Intangibles -- 0.00 245,358 129,367
Asset Impairment Charge 2.8M 0.00 2.1M 0.00
Cash Dividends Paid -- 0.00 0.00 --
Change In Prepaid Assets -1.6M -76,888 -1,474 -21,780
Common Stock Issuance 29.8M 24.5M 2.0M 5.6M
Depreciation 13,935 5,277 2,947 580.38
Gain Loss On Investment Securities 1,394 -753.81 -33,156 369.41
Interest Paid Cff -- -70,104 0.00 --
Long Term Debt Issuance 0.00 1.7M 0.00 146,329
Long Term Debt Payments 0.00 -2.0M 0.00 --
Net Business Purchase And Sale -- -- 0.00 1.4M
Net Foreign Currency Exchange Gain Loss -1.0M 872,154 51,577 -15,878
Net Income From Continuing Operations -19.6M -12.0M -8.3M -12.2M
Net Long Term Debt Issuance 0.00 -284,939 0.00 146,329
Net Other Financing Charges -- 454,545 -- --
Net Other Investing Changes -- -- -- 1.4M
Operating Gains Losses -1.0M 1.2M 18,420 -15,509
Proceeds From Stock Option Exercised 7.4M 13.8M 0.00 145,459
NEWS
Loading news...
TRENDING
Loading...